—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Liquidia Technologies Inc（LQDA）— 同業公司組

數據截至2026-10-29 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

Liquidia Technologies Inc的Closelook綜合評分為47/100，在同業公司組內排名第7位（共7家）——組內評分最高的是Laboratorios Farmaceuticos ROVI（62/100）。

名稱綜合動能品質估值訊號距52週高點
LQDA Liquidia Technologies Inc47336831info51.9%
ROVI.MC Laboratorios Farmaceuticos ROVI62347750info27.8%
LNTH Lantheus Holdings Inc60727454ok10.3%
BHC.TO Bausch Health Companies Inc58927182info1.9%
GALDY GALDERMA GROUP AG57706022info1.6%
KNSA Kiniksa Pharmaceuticals Ltd57975918ok0.8%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock56935846ok1.5%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-29

Quick answers

Liquidia Technologies Inc在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)。

LQDA相對同業公司的評分如何？

Liquidia Technologies Inc的綜合評分為47/100，組內排名第7位（共7家），截至2026-10-29；組內最高綜合評分為Laboratorios Farmaceuticos ROVI（62/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.